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Corrigendum
Teus MA, Miglior S, Laganovska G, et al. Efficacy and safety 
of travoprost/  timolol vs dorzolamide/timolol in patients with 
open-angle glaucoma or ocular   hypertension. Clin Ophthal-
mol. 2009;3:629–636.
The footnote of Table 4 should read: 
DUOTRAV = Travoprost 40 ug/mL + Timolol 5 mg/mL eye 
drops, solution. Cosopt = Dorzolamide 20 mg/mL + Timolol 
5 mg/mL eye drops, solution. 
Estimates based on descriptive statistics.